- VXRT +2.01%
While institutions invested in Vaxart, Inc. (NASDAQ:VXRT) benefited from last week's 23% gain, retail investors stood to gain the most
Yahoo Finance · 2 weeks ago
Open | 0.6500 |
High | 0.6646 |
Low | 0.6450 |
Mkt Cap | 116.8M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 0.6453 |
52 Wk. Low | 0.5200 |
52 Wk. High | 1.5400 |
Related stocks
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 2.18M | 223.10% ▲ |
Net Income | -24.42M | - |
Diluted EPS | -0.14 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.03 | - |
Q1 2024 | -$0.14 | -$0.14 |
Q4 2023 | -$0.14 | -$0.12 |
S&P FuturesES=F | 5,615.00-6.50 (-0.12%) |
Dow FuturesYM=F | 39,638.00-57.00 (-0.14%) |
Nasdaq FuturesNQ=F | 20,599.50-21.25 (-0.10%) |
20,599.50-0.10% | |
5,615.00-0.12% | |
39,638.00-0.14% |